Folic acid reduces risk of neural tube defects linked to HIV drug dolutegravir

(Baylor College of Medicine) HIV drug doluteglavir interferes with the binding of folate to its receptor, thus promoting neural tube defects. Folic acid supplementation can mitigate the risk of the medication in an animal model.